[Organoid-based therapy].

Nihon Shokakibyo Gakkai Zasshi

Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University (TMDU).

Published: December 2023

Download full-text PDF

Source
http://dx.doi.org/10.11405/nisshoshi.120.964DOI Listing

Publication Analysis

Top Keywords

[organoid-based therapy]
4
[organoid-based
1

Similar Publications

Lung cancer is a malignant tumor with high incidence and mortality rates in both men and women worldwide. Although anticancer drugs are prescribed to treat lung cancer patients, individual responses to these drugs vary, making it crucial to identify the most suitable treatment for each patient. Therefore, it is necessary to develop an anticancer drug efficacy prediction model that can analyze drug efficacy before patient treatment and establish personalized treatment strategies.

View Article and Find Full Text PDF

Organoid models of drug resistant gastric adenosquamous carcinoma: Recapitulating tumor features and refining precision treatment.

Drug Resist Updat

January 2025

Digestive Diseases Center, Guangdong Provincial Key Laboratory of Digestive Cancer Research, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, Guangdong 518107, China; The Biobank, Scientific Research Center, Guangdong Provincial Key Laboratory of Digestive Cancer Research, The Seventh Affiliated Hospital of Sun Yat-Sen University, Shenzhen, Guangdong 518107, China. Electronic address:

Article Synopsis
  • Organoids were created from a patient's primary tumor and metastatic lymph nodes, accurately mirroring the tumor's characteristics.
  • Drug testing on these organoids showed distinct differences in how they responded to treatments based on their origin (primary vs. metastatic).
  • This personalized approach to using organoids aids in making informed treatment decisions for gastric cancer, potentially improving patient outcomes.
View Article and Find Full Text PDF

The lack of a robust system to reproducibly propagate HRV-C, a family of viruses refractory to cultivation in standard cell lines, has substantially hindered our understanding of this common respiratory pathogen. We sought to develop an organoid-based system to reproducibly propagate HRV-C, and characterize virus-host interaction using respiratory organoids. We demonstrate that airway organoids sustain serial virus passage with the aid of CYT387-mediated immunosuppression, whereas nasal organoids that more closely simulate the upper airway achieve this without any intervention.

View Article and Find Full Text PDF

Organoid-based precision medicine in pancreatic cancer.

United European Gastroenterol J

November 2024

Institute of Molecular Oncology and Stem Cell Biology, Ulm University Hospital, Ulm, Germany.

Pancreatic ductal adenocarcinoma (PDAC) ranks among the leading causes of cancer-related deaths worldwide. Despite advances in precision oncology in other malignancies, treatment of PDAC still largely relies on conventional chemotherapy. Given the dismal prognosis and heterogeneity in PDAC, there is an urgent need for personalized therapeutic strategies to improve treatment response.

View Article and Find Full Text PDF

Urothelial carcinoma (UC) of the urinary bladder has significant challenges in treatment due to its diverse genetic landscape and variable response to systemic therapy. In recent years, patient-derived organoids (PDOs) emerged as a novel tool to model primary tumors with higher resemblance than conventional 2D cell culture approaches. However, the potential of organoids to predict therapy response in a clinical setting remains to be evaluated.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!